Cart
sales@molnova.com
TC-G-1008
CAS No. 1621175-65-2
TC-G-1008 ( GPR39-C3, GPR39 C3, TC-G-1008, TCG1008, TCG 1008 )
Catalog No. M18094 CAS No. 1621175-65-2
TC-G-1008 is a GPR39 (zinc receptor) agonist (EC50 values are 0.4 and 0.8 nM for rat and human receptors respectively).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 53 | In Stock |
|
| 5MG | 83 | In Stock |
|
| 10MG | 143 | In Stock |
|
| 25MG | 303 | In Stock |
|
| 50MG | 519 | In Stock |
|
| 100MG | 746 | In Stock |
|
| 500MG | 1512 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTC-G-1008
-
NoteResearch use only, not for human use.
-
Brief DescriptionTC-G-1008 is a GPR39 (zinc receptor) agonist (EC50 values are 0.4 and 0.8 nM for rat and human receptors respectively).
-
DescriptionTC-G-1008, also known as GPR39-C3, is a GPR39 (zinc receptor) agonist (EC50 values are 0.4 and 0.8 nM for rat and human receptors respectively).
-
SynonymsGPR39-C3, GPR39 C3, TC-G-1008, TCG1008, TCG 1008
-
PathwayOthers
-
TargetOther Targets
-
Recptorrat GPR39; human GPR39
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1621175-65-2
-
Formula Weight418.9
-
Molecular FormulaC18H19ClN6O2S
-
Purity98%
-
SolubilityDMSO : ≥ 100 mg/mL; 238.72 mM
-
SMILESCNc2nc(cc(NCc1ccc(NS(C)(=O)=O)cc1Cl)n2)c3ccccn3
-
Chemical NameN-[3-Chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peukert S, et al. Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists. ACS Med Chem Lett. 2014 Aug 4;5(10):1114-8.
molnova catalog
related products
-
Iristectorin A-6-O-g...
The herbs of Iris tectorum.
-
3-O-Methylbatatasin ...
3'-O-Methylbatatasin III is a natural compound from the orchid plant Bletilla splendens with antibiotic activity and antispasmodic activity.
-
Combretol
Combretol has leishmanicidal activity, it showed moderate activity (growth inhibition 87.3 and 73.0 %, respectively, at 50 μM) against a multidrug-resistant L. tropica line. Combretol also shows weakly active cytotoxic activity.
